We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Impax Laboratories announced it has signed an agreement with Purdue Pharma and certain of its affiliates to settle patent infringement litigation pertaining to Impax's generic versions of Purdue's OxyContin.
Roche has expanded its preclinical drug-discovery platforms with a $56.5 million acquisition of Therapeutic Human Polyclonals (THP), the Swiss drugmaker said.
Indian drugmaker Ranbaxy Laboratories has announced that, as part of its collaboration agreement with GlaxoSmithKline (GSK), the companies have selected a compound to develop for the treatment of respiratory inflammation.
South Africa's National AIDS Council, in its capacity as the country coordinator for the Global Fund to fight AIDS, Tuberculosis (TB) and Malaria, has called on organizations to submit proposals for the seventh round of funding.
The European Medicines Agency (EMEA) has recommended restrictions on the use of sanofi-aventis' antibiotic Ketek for three of its four approved indications.